Ampliando a utilização da terapia de reperfusão: do GISSI ao DANAMI Expanding the use of reperfusion therapy: from GISSI to DANAMI

Slični predmeti

• Misleading subgroup analyses in GISSI
  od: Peto, R
  Izdano: (1990)
• GISSI-2: 10% reduction in mortality with heparin in acute myocardial infarction?
  od: Collins, R, i dr.
  Izdano: (1990)
• Relation between plasma ceramides and cardiovascular death in chronic heart failure: A subset analysis of the GISSI‐HF trial
  od: Giovanni Targher, i dr.
  Izdano: (2020-12-01)
• Cardiovascular magnetic resonance characteristics and clinical outcomes of patients with ST-elevation myocardial infarction and no standard modifiable risk factors–A DANAMI-3 substudy
  od: Jawad Mazhar, i dr.
  Izdano: (2022-08-01)
• ISIS-3 and GISSI-2: no survival advantage with tissue plasminogen activator over streptokinase, but a significant excess of strokes with tissue plasminogen activator in both trials.
  od: Collins, R, i dr.
  Izdano: (1993)